Tamar Zahavi

Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

The Impact of Minimal Residual Disease (MRD) Testing on the Decision-Making Process in Non-Small-Cell Lung Cancer (NSCLC).

The Impact of Minimal Residual Disease (MRD) Testing on the Decision-Making Process in Non-Small-Cell Lung Cancer (NSCLC).

Journal: Cancers
Published: March 16, 2026

Refining prognostic tools for luminal breast cancer: genetic insights and comprehensive analysis.

Refining prognostic tools for luminal breast cancer: genetic insights and comprehensive analysis.

Journal: ESMO open
Published: September 02, 2024

Unlocking prognostic potential: A genomic signature of caloric restriction in patients with epithelial ovarian cancer.

Unlocking prognostic potential: A genomic signature of caloric restriction in patients with epithelial ovarian cancer.

Journal: PloS one
Published: July 04, 2024

Exploring potential biomarkers and therapeutic targets in inflammatory bowel disease: insights from a mega-analysis approach.

Exploring potential biomarkers and therapeutic targets in inflammatory bowel disease: insights from a mega-analysis approach.

Journal: Frontiers in immunology
Published: December 11, 2023

Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer.

Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer.

Journal: Scientific reports
Published: July 11, 2023

The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.

The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.

Journal: ESMO open
Published: August 17, 2022

Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment.

Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment.

Journal: Genes
Published: July 31, 2022

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer.

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer.

Journal: NPJ breast cancer
Published: September 15, 2020

The Acidic Stress Response of the Intracellular Pathogen Brucella melitensis: New Insights from a Comparative, Genome-Wide Transcriptome Analysis.

The Acidic Stress Response of the Intracellular Pathogen Brucella melitensis: New Insights from a Comparative, Genome-Wide Transcriptome Analysis.

Journal: Genes
Published: July 14, 2020

Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer.

Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer.

Journal: International journal of cancer
Published: August 01, 2019

Transcriptomic Analysis of the Brucella melitensis Rev.1 Vaccine Strain in an Acidic Environment: Insights Into Virulence Attenuation.

Transcriptomic Analysis of the Brucella melitensis Rev.1 Vaccine Strain in an Acidic Environment: Insights Into Virulence Attenuation.

Journal: Frontiers in microbiology
Published: October 24, 2018

SYK expression level distinguishes control from BRCA1-mutated lymphocytes.

SYK expression level distinguishes control from BRCA1-mutated lymphocytes.

Journal: Cancer management and research
Published: April 06, 2018
Showing 1-12 of 19

Last Updated: 09/26/2026